Palantir, Tyson Foods, BioNTech Fall Premarket; Signify Health Rises
2022.08.08 16:14
By Peter Nurse
Investing.com — Stocks in focus in premarket trade on Monday, August 8th. Please refresh for updates.
-
Palantir (NYSE:PLTR) stock slumped 14.5% after the data analytics software company lowered its annual revenue forecast, saying the timing of some large government contracts remained uncertain.
-
Signify Health (NYSE:SGFY) stock rose 18% after the Wall Street Journal reported that CVS Health (NYSE:CVS), up 0.6%, is seeking to buy its rival, aiming to expand its push into the provision of medical services.
-
Global Blood Therapeutics (NASDAQ:GBT) stock rose 4.3% after Pfizer (NYSE:PFE) confirmed it intends to buy the blood disorder drugmaker in a $5.4 billion deal, as it looks to boost its pipeline to combat a potential slowdown in COVID product demand.
-
Tyson Foods (NYSE:TSN) stock fell 4.9% after demand for the meat producer’s chicken and beef remained steady, but fears increased that decades-high inflation will result in surging costs going forward.
-
BioNTech (NASDAQ:BNTX) stock fell 6.2% after the German medicine maker posted less-than-expected second quarter revenues and earnings despite backing its full-year guidance.
-
Twitter (NYSE:TWTR) stock rose 1.79% after Elon Musk said his $44 billion deal to buy the social messaging network should proceed on its original terms if the company could provide its method of sampling 100 accounts and how it confirmed that the accounts are real.
-
First Solar (NASDAQ:FSLR) stock 6% after JPMorgan upgraded its stance on the manufacturer of solar panels to ‘buy’ from ‘hold’, saying the newly-passed climate bill should help the stock climb 20%.
-
Roku (NASDAQ:ROKU) stock fell 2% after Pivotal downgraded its stance on the streaming company to ‘sell’ from ‘hold’, saying its faces further downside with a recession coming.
